NCT00514683 Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT00504621 The Influence of Personality on Pulmonary Fibrosis and Sarcoidosis Status COMPLETED Phase N/A
NCT00467831 Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome Status TERMINATED Phase PHASE1/PHASE2
NCT00457301 Using Health-related Quality of Life (HRQL) in Routine Clinical Care Status COMPLETED Phase N/A
NCT00455767 Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients Status COMPLETED Phase PHASE2
NCT00439543 Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis Status UNKNOWN Phase PHASE2/PHASE3
NCT00366509 Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases Status COMPLETED Phase N/A
NCT00352482 Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension Status COMPLETED Phase PHASE2
NCT00258544 Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00109681 Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT00084305 Analysis of Specimens From Individuals With Pulmonary Fibrosis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00080223 Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT00076635 An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF Status TERMINATED Phase PHASE3
NCT00075998 The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE3
NCT00070590 Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma Status COMPLETED Phase PHASE2/PHASE3
NCT00063869 Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT00052052 An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2